Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q2 2023 · 10-Q
Revenue$2.17B$2.17B+10.2% vs Q2 2022 Net Income$26.00M$26.00MN/M vs Q2 2022 EPS Diluted$0.07$0.07N/M vs Q2 2022 Operating Income$412,000,000+155.9% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$178,000,000+150.7% Margins · derivedOperating margin19.0%+10.8 pt vs Q2 2022
Net margin1.2%+8.6 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 3, 2023 · 34 d after period end